Skip to Main Content

Paper Details

Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases.
Dig Dis Sci
9
2022
IBD, ICD codes, Inflammatory Bowel Diseases, Patients, TNF, Thrombotic and Cardiovascular Events, Tofacitinib, VTE, anti-TNF, anti-TNFs, cardiovascular, inflammatory bowel disease, patients, thromboembolic, thromboembolic and cardiovascular events, tofacitinib, tumor necrosis factor, venous thromboembolism
Author NameAffiliation
Tianxi CaiHarvard Medical School
Tianxi CaiHarvard Medical School
Ashwin N AnanthakrishnanMassachusetts General Hospital and Harvard Medical School
Ashwin N Ananthakrishnan
  • 1 - 4

Datasets

Release 1.2